BPADBipolar Affective Disorder
BPADBroadcast Public Affairs Detachment
BPADBisynchronous Packet Assembler/Disassembler
References in periodicals archive ?
Given the lack of data on PAC among caregivers of patients with BPAD, the present study aimed to assess PAC (using SPACE) and its correlates (socio-demographic and clinical variables, caregiver burden, coping, QOL, and psychological morbidity) in the primary caregivers of patients with BPAD.
Patients were included in the study if they had a diagnosis of BPAD as per the DSM-IV (33) (by Mini-International Neuropsychiatry Interview [MINI] (34)); aged between 18 and 65 years; illness duration of at least 1 year and currently in remission (i.
50] values (the concentration at 50% of maximum activity) as PODs in their illustration of the BPAD concept.
Second-generation antipsychotic drugs (SGA) are commonly used for the treatment of BPAD.
By doing this study, we could know the prevalence of MetS at baseline in drug-naive and drug-free BPAD patients and we will be able to decide risk and benefits of SGA in the treatment of bipolar disorder.
12) BPAD constituted 13%, OCD 11% and dementia 6% of the cases in this study.
This finding is in contradiction to the usual understanding of schizophrenia being a more disabling condition compared to BPAD and OCD.
After adjustment for all potential con-founders except maternal age, the hazard ratios for risk of BPAD for each 10-year increase in paternal age was 1.
3 Depression 6 9 Psychosis 4 6 Dual diagnosis Conduct disorder 4 6 BPAD 2 3 Schizophrenia 1 1.
Almost similar percentage of cases of BPAD with major depression (40%) had low serum total cholesterol levels.
05 Married 32(64%) Widowed 4(8%) Divorced 4(8%) Separated 4(8%) Others 0(0%) Table 2: Clinical profile of the cases & controls Variables Cases (n=100) With suicide With suicidal attempt ideations only n=50 n=50 Serum Total 160-200mg% 25(50%) 32(64%) cholesterol 145-159mg% 10(20%) 16(32%) levels < 145mg% 15(30%) 0(0%) >200mg% 0(0%) 2(4%) Diagnosis Major Depression 16(32%) 10(20%) Mild and moderate -- 3(6%) depression Schizophrenia 15(30%) 9(18%) Substance dependence 10(20%) 6(12%) BPAD with mania -- -- BPAD with major 9(18%) 7(14%) depression Anxiety disorders -- 11(22%) Others -- 4(8%) Variables Controls p value (n=50) Serum Total 160-200mg% 47(94%) 0.